Hyperimmune Egg Product for Dysbiosis Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for dysbiosis, a microbial imbalance in the gastrointestinal tract, are often ineffective and associated with side effects, and fail to address the underlying inflammation contributing to chronic and degenerative diseases such as irritable bowel syndrome and rheumatoid arthritis.

Innovation Solution

Administration of a hyperimmune egg product, optionally combined with probiotics and nutrient sources, to increase beneficial flora, decrease intestinal permeability, and treat or prevent dysbiosis, particularly in subjects with conditions like Crohn's disease and inflammatory bowel disease.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional treatments are used for dysbiosis, then some therapeutic effect may be achieved, but side effects occur and effectiveness is limited

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent uses hyperimmune egg product as an intermediary substance that mediates the treatment of dysbiosis. The egg product contains immunoglobulins that act as intermediaries to modulate the gut microbiota and reduce inflammation, providing therapeutic effects without the harmful side effects of conventional medications.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The treatment approach changes the parameters of the gastrointestinal system by introducing hyperimmune egg product which alters the immune response parameters, microbiota composition parameters, and inflammation levels, thereby treating dysbiosis through parameter modification rather than direct suppression.

Inventive Principle:
Principle #35Parameter changes

2Object-generated harmful factors

If antibiotics are used to treat dysbiosis, then bacterial overgrowth may be reduced, but beneficial flora is also depleted and side effects increase

Engineering Contradiction:
Improvepathogenic microorganism overgrowthVSAvoidbeneficial flora levels
Core Design Contradiction:
Object-generated harmful factorsVSQuantity of substance

Solution Approach 1:

The patent converts the harmful effect of broad-spectrum antibiotic use into a beneficial outcome by using hyperimmune egg product that selectively targets pathogenic microorganisms while preserving beneficial flora. The immunoglobulins in the egg product distinguish between harmful and beneficial bacteria, eliminating pathogens without depleting beneficial flora.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The hyperimmune egg product serves as an intermediary that provides selective pressure against pathogenic microorganisms while maintaining the beneficial flora. The immunoglobulins act as mediators that specifically bind to and neutralize harmful bacteria without affecting beneficial species.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Quantity of substance

If probiotics are administered alone, then beneficial flora levels may increase, but effectiveness is limited without addressing underlying inflammation

Engineering Contradiction:
Improvebeneficial flora levelsVSAvoidtreatment effectiveness
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent merges probiotic administration with hyperimmune egg product supplementation to create a combined therapeutic approach. This combination integrates the benefits of increased beneficial flora from probiotics with the anti-inflammatory and immunomodulatory effects of the hyperimmune egg product, resulting in enhanced overall treatment effectiveness.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The hyperimmune egg product provides multiple functions simultaneously: it increases beneficial flora levels, reduces inflammation, modulates immune response, and addresses underlying causes of dysbiosis. This multi-functionality makes the treatment more effective than single-mechanism approaches.

Inventive Principle:
Principle #6Universality (Multi-functionality)

4Object-affected harmful factors

If inflammation is suppressed with conventional medications, then symptoms may be reduced, but underlying dysbiosis is not addressed and side effects occur

Engineering Contradiction:
Improveinflammation levelsVSAvoidlong-term treatment effectiveness
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent applies preliminary action by using hyperimmune egg product to address the underlying dysbiosis and immune dysfunction before inflammation becomes severe. The treatment works preventively and fundamentally by restoring microbial balance and immune function, thereby preventing chronic inflammation rather than merely suppressing symptoms.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The treatment converts the harmful chronic inflammation into a beneficial state by using hyperimmune egg product to restore immune balance. The immunoglobulins in the egg product transform the inflammatory response from harmful to protective, addressing the root cause rather than suppressing symptoms.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The hyperimmune egg product, when administered with probiotics or nutrient sources, effectively increases beneficial flora, reduces intestinal permeability, and treats or prevents dysbiosis, improving symptoms and quality of life without significant side effects.

Implementation Method 1

administering a hyperimmune egg product to treat or prevent dysbiosis

Methodology Applied
Scientific EffectImmune modulation:

Implementation Method 2

hyperimmune egg product obtained by treating an egg-producing animal with a vaccine

Methodology Applied
Scientific EffectHyperimmunization:

Data Source

PatentUS10632158B2Use of a hyperimmune egg product to prevent and treat dysbiosis
Publication Date: 2020.04.28 IGY NUTRITION
  • US10632158B2 patent drawing
  • US10632158B2 patent drawing
  • US10632158B2 patent drawing

AI summary

Methods for treating and preventing dysbiosis in a subject suffering from or susceptible to gastrointestinal disorders are described. The methods comprises administering a hyperimmunized egg product to the subject, wherein the egg product is obtained from a hyperimmunized avian, optionally in combination with an additional compound such as a probiotic and/or nutrient source.